Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose Rosa M.R. Pereira; Marilia A. Dagostin; Valeria F. Caparbo; Lucas P. Sales; Sandra G. Pasoto; Clovis A. Silva; Emily F.N. Yuki; Carla G.S. Saad; Ana C. Medeiros-Ribeiro; Leonard V.K. Kupa; Solange R.G. Fusco; Victor A.O. Martins; Carolina C.M.F. Martins; Carmen Valente Barbas; Samuel K. Shinjo; Nadia E. Aikawa; Eloisa Bonfa;